Australian Pharmaceuticals & Biotech Profitable Climbers

Clinuvel Pharmaceuticals

Market Cap: AU$583.3m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Medical Developments International

Market Cap: AU$52.4m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Telix Pharmaceuticals

Market Cap: AU$3.4b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.